Search research articles
Contact Us
Filters
Showing results (91-100 of 112) with videos related to
Page
of 12
Sort By:
United European Gastroenterology Journal
|
March 28, 2020
Gastric cancer in autoimmune gastritis: A case-control study from the German centers of the staR project on gastric cancer research
Friederike Weise, Michael Vieth, Dirk Reinhold, et al.
Liver Cancer
|
August 20, 2021
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort
Fabian Finkelmeier, Bernhard Scheiner, Catherine Leyh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 9, 2022
Secondary Sclerosing Cholangitis Following Coronavirus Disease 2019 (COVID-19): A Multicenter Retrospective Study
Peter Hunyady, Lea Streller, Darius F Rüther, et al.
Cancers
|
December 11, 2022
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience
Friedrich Sinner, Matthias Pinter, Bernhard Scheiner, et al.
Annals of Hepatology
|
August 15, 2024
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma
Louisa Stern, Constantin Schmidt, Lorenz Kocheise, et al.
Biochemical and Biophysical Research Communications
|
July 21, 2024
The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects
Anne Dropmann, Sophie Alex, Katharina Schorn, et al.
Liver Cancer
|
August 11, 2022
Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study
Sabrina Welland, Catherine Leyh, Fabian Finkelmeier, et al.
Cell Death & Disease
|
October 18, 2020
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Anna-Lena Scherr, Andreas Mock, Georg Gdynia, et al.
Hepatology Communications
|
November 4, 2024
Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort
Tiago de Castro, Sabrina Welland, Leonie Jochheim, et al.
Journal of Hepatology
|
October 14, 2021
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score
Bernhard Scheiner, Katharina Pomej, Martha M Kirstein, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 112) with videos related to
Sort By:
Page
of 12
United European Gastroenterology Journal
|
March 28, 2020
Gastric cancer in autoimmune gastritis: A case-control study from the German centers of the staR project on gastric cancer research
Friederike Weise, Michael Vieth, Dirk Reinhold, et al.
Liver Cancer
|
August 20, 2021
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort
Fabian Finkelmeier, Bernhard Scheiner, Catherine Leyh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 9, 2022
Secondary Sclerosing Cholangitis Following Coronavirus Disease 2019 (COVID-19): A Multicenter Retrospective Study
Peter Hunyady, Lea Streller, Darius F Rüther, et al.
Cancers
|
December 11, 2022
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience
Friedrich Sinner, Matthias Pinter, Bernhard Scheiner, et al.
Annals of Hepatology
|
August 15, 2024
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma
Louisa Stern, Constantin Schmidt, Lorenz Kocheise, et al.
Biochemical and Biophysical Research Communications
|
July 21, 2024
The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects
Anne Dropmann, Sophie Alex, Katharina Schorn, et al.
Liver Cancer
|
August 11, 2022
Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study
Sabrina Welland, Catherine Leyh, Fabian Finkelmeier, et al.
Cell Death & Disease
|
October 18, 2020
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Anna-Lena Scherr, Andreas Mock, Georg Gdynia, et al.
Hepatology Communications
|
November 4, 2024
Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort
Tiago de Castro, Sabrina Welland, Leonie Jochheim, et al.
Journal of Hepatology
|
October 14, 2021
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score
Bernhard Scheiner, Katharina Pomej, Martha M Kirstein, et al.
Page
of 12